These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28935368)

  • 1. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
    Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
    Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBE2S enhances the ubiquitination of p53 and exerts oncogenic activities in hepatocellular carcinoma.
    Pan YH; Yang M; Liu LP; Wu DC; Li MY; Su SG
    Biochem Biophys Res Commun; 2018 Sep; 503(2):895-902. PubMed ID: 29928880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
    Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
    J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism.
    Zhu Z; Cao C; Zhang D; Zhang Z; Liu L; Wu D; Sun J
    Cell Death Dis; 2022 Feb; 13(2):154. PubMed ID: 35169125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
    Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
    Guo J; Wang M; Wang JP; Wu CX
    World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression.
    Ren X; Li A; Ying E; Fang J; Li M; Yu J
    Bioengineered; 2021 Dec; 12(1):1530-1542. PubMed ID: 33934686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_0000291 contributes to hepatocellular carcinoma tumorigenesis by binding to miR-1322 to up-regulate UBE2T.
    Wang F; Zhong S; Mao C; Jin J; Wang H
    Ann Hepatol; 2022; 27(5):100722. PubMed ID: 35569812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T.
    Tao Y; Li R; Shen C; Li J; Zhang Q; Ma Z; Wang F; Wang Z
    Aging (Albany NY); 2020 Jan; 12(2):1563-1576. PubMed ID: 31969492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBE2T promotes glioblastoma malignancy through ubiquitination-mediated degradation of RPL6.
    Tao X; Wu X; Zhou P; Yu X; Zhao C; Peng X; Zhang K; Shen L; Peng J; Yang L
    Cancer Sci; 2023 Feb; 114(2):521-532. PubMed ID: 36156329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.
    Yang YF; Zhang MF; Tian QH; Zhang CZ
    J Cell Sci; 2017 Sep; 130(18):3108-3115. PubMed ID: 28754688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression.
    Ho NPY; Leung CON; Wong TL; Lau EYT; Lei MML; Mok EHK; Leung HW; Tong M; Ng IOL; Yun JP; Ma S; Lee TKW
    Cell Death Dis; 2021 Feb; 12(2):148. PubMed ID: 33542213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
    Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
    Chen L; Luo L; Chen W; Xu HX; Chen F; Chen LZ; Zeng WT; Chen JS; Huang XH
    Biomed Pharmacother; 2016 Dec; 84():1113-1118. PubMed ID: 27780140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MARCH5 promotes hepatocellular carcinoma progression by inducing p53 ubiquitination degradation.
    Cai X; Gao J; Yan Z; Zhang H; Guo D; Zhang S
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):303. PubMed ID: 38861187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXK2, regulted by miR-1271-5p, promotes cell growth and indicates unfavorable prognosis in hepatocellular carcinoma.
    Lin MF; Yang YF; Peng ZP; Zhang MF; Liang JY; Chen W; Liu XH; Zheng YL
    Int J Biochem Cell Biol; 2017 Jul; 88():155-161. PubMed ID: 28506857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma.
    Chen SL; Zhang CZ; Liu LL; Lu SX; Pan YH; Wang CH; He YF; Lin CS; Yang X; Xie D; Yun JP
    Cancer Res; 2019 Feb; 79(3):534-545. PubMed ID: 30584071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UBE2T promotes β-catenin nuclear translocation in hepatocellular carcinoma through MAPK/ERK-dependent activation.
    Lioulia E; Mokos P; Panteris E; Dafou D
    Mol Oncol; 2022 Apr; 16(8):1694-1713. PubMed ID: 34614271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression.
    Yu H; Xiang P; Pan Q; Huang Y; Xie N; Zhu W
    Tumour Biol; 2016 Sep; 37(9):11723-11732. PubMed ID: 27020591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.